Inventor · disambiguated record
Andrew Bogdan
Also filed as: BOGDAN ANDREW
19 granted patents·26 pending applications·134 citations·filing 2013–2024
93Inventor score
Top patents by PatentIndex Score
45 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0394US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0491US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0588US8980879B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Mar 17, 2015·11 cites·32 claims
- 0685US9452986B26-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of useABBVIE INC·Filed 2015·Granted Sep 27, 2016·5 cites·27 claims
- 0784US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 0884US2025145587A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 0982US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 1082US9969693B26-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of useABBVIE INC·Filed 2016·Granted May 15, 2018·3 cites·11 claims
- 1179US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 1279US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 1378US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 1478US10085985B2Bromodomain inhibitorsABBVIE INC·Filed 2016·Granted Oct 2, 2018·2 cites·21 claims
- 1578US10035800B2Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jul 31, 2018·3 cites·48 claims
- 1674US2023101559A1Bromodomain InhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 1772US9428514B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Aug 30, 2016·1 cites·24 claims
- 1872US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 1971US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2071US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2171US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 2270US2021070756A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2369US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 2468US2021253551A1Bromodomain InhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2568US2020291027A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2663US2019389861A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 2763US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 2862US2025122160A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2024·Application pending·0 cites
- 2961US2018298003A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 3060US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 3159US2024043386A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2023·Application pending·0 cites
- 3259US2024158368A1Pyrrolidine Main Protease Inhibitors as Antiviral AgentsABBVIE INC·Filed 2023·Application pending·0 cites
- 3359US2020048220A1Bromodomain InhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3458US2025042894A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 3557US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 3656US2025019374A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 3756US2019008866A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 3855US2018334435A16-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of useABBVIE INC·Filed 2018·Application pending·0 cites
- 3955US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 4055US2023019236A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 4154US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 4253US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 4352US2022213041A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
- 4440US2015150884A1Bromodomain inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 4539US2014073700A1Glycyrrhetinic acid derivatives and methods of use thereofABBVIE INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Bogdan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →